HCM Beat
19 FOLLOWERS
A news and informational website about the common genetic heart condition, hypertrophic cardiomyopathy. Summarizes the latest research and interviews researchers and other notable people in the HCM community.
HCM Beat
5d ago
Ninerafaxstat, an investigational drug being studied by Imbria Pharmaceuticals, may be the first drug specifically for non-obstructive hypertrophic cardiomyopathy ..read more
HCM Beat
4M ago
Cytokinetics today released positive results from Sequoia-HCM, its Phase 3 clinical trial of the experimental drug aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). ..read more
HCM Beat
5M ago
According to a recent overview by HCM specialists at the Lahey Clinic, the prognosis for patients with HCM and atrial fibrillation has substantially improved in recent years ..read more
HCM Beat
7M ago
Tenaya Therapeutics and the Cleveland Clinic today announced that the first patient in Tenaya's groundbreaking gene therapy clinical trial for hypertrophic cardiomyopathy has been dosed ..read more
HCM Beat
8M ago
Viz.ai has received FDA approval for an artificial intelligence algorithm that can spot HCM from a standard electrocardiogram or EKG ..read more
HCM Beat
9M ago
A paper published this week in the Journal of the American College of Cardiology described the first beating heart septal myectomies performed on patients with obstructive HCM ..read more
HCM Beat
9M ago
Novel imaging techniques appear to detect pre-clinical HCM before the development of any thickening in the heart ..read more
HCM Beat
10M ago
The FDA has announced a Class I recall of certain models of Medtronic implantable defibrillators and cardiac resynchronization therapy defibrillators ..read more
HCM Beat
10M ago
Recently, Cynthia Waldman of HCMBeat had the chance to discuss gene therapy and Tenaya Therapeutics' upcoming clinical trial with Dr. Laura Robertson of Tenaya ..read more
HCM Beat
10M ago
Bristol Myers Squibb’s myosin modulator mavacamten (brand name Camzyos) has been approved for the treatment of obstructive hypertrophic cardiomyopathy in all countries which are part of the European Union ..read more